Klp Kapitalforvaltning As Pacira Bio Sciences, Inc. Transaction History
Klp Kapitalforvaltning As
- $22.5 Billion
- Q2 2025
A detailed history of Klp Kapitalforvaltning As transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 35,200 shares of PCRX stock, worth $873,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,200
Previous 23,700
48.52%
Holding current value
$873,312
Previous $588,000
43.03%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
261Shares Held
51.6MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$199 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$134 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$59.4 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$56.2 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$53.4 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.14B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...